SGCB and cancer: Four major categories of NO-based anti-cancer therapies—NO donors, phosphodiesterase inhibitors (PDE-i), soluble guanylyl cyclase (sGC) activators, and immunomodulators NO to target cancer cells, offering promising avenues for treatment (Mintz et al., 2021).